Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs
🤖AI Özeti
Dozens of MPs are voicing opposition to Health Secretary Wes Streeting's decision to grant himself the authority to determine NHS drug pricing, raising concerns about the legality of this move. A motion signed by thirty-one MPs criticizes the potential override of the National Institute for Health and Care Excellence's (Nice) assessments on drug costs. Critics argue that this 'power grab' could disproportionately benefit large pharmaceutical companies.
💡AI Analizi
📚Bağlam ve Tarihsel Perspektif
The National Institute for Health and Care Excellence (Nice) plays a critical role in determining the cost-effectiveness of medications for the NHS. The proposed changes by the health secretary come at a time when the NHS is facing financial pressures and scrutiny over drug pricing, making this issue particularly contentious.
This article reflects the opinions and perspectives of its sources and does not necessarily represent the views of the newsroom.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.